Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients
In a prospective, randomized, double-blind trial, the effects of two different dosages of LMWH (5000 anti-Xa U od sc and 10 000 anti-Xa U od sc daily) on markers of hemostatic system and thrombin generation will be investigated in non-surgical cancer patients will be investigated.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
|Official Title:||Prevention of Venous Thrombosis in Cancer Patients: A Prospective, Randomized, Double-blind Study Comparing Two Different Dosages of Low-molecular Weight Heparin|